分子别称:CI-M6PR,CIMPR 义翘神州还可以提供高质量的抗体制备、生产服务,尤其是重组抗体的生产,可以实现高通量生产、大规模生产。具体可以前往官网查询,或关注公众号咨询。 公司简介 北京义翘神州科技股份有限公司(Sino Biological Inc.)成立于2007年,凭借多元化的技术平台和 的人才队伍,义翘神州建立了 的重组蛋白和单...
英文名称:IGF2R/M6PR 纯度:> 99% 包装信息:50ul/RMB 1098;100ul/RMB 1880;200ul/RMB 2900 备注:300 kDa mannose 6-phosphate receptor; Cation independent mannose 6 phosphate receptor; Cation-independent mannose-6-phosphate receptor; CD222; CD222 antigen; CI Man 6 P receptor; C ...
关键字:IGF2R/M6PR;CD222;CD222 antigen;Man 6 P receptor;CI Man-6-P receptor; CI MPR;MPR300;MPRI_HUMAN; 公司简介 上海沪震实业有限公司是一家集研发、生产和销售于一体的生命科学实验室产品生物科技企业。主营产品:试剂盒,ELISA试剂盒,抗体,重组蛋白,血清,胎牛血清,细胞,原代细胞 细胞培养试剂,常用生...
抗体名称 Anti-IGF2R Antibody (Clone#6G2) 指标别名 CD222;CI Man 6 P receptor;CI MPR;CIMPR;IGF II receptor;IGF2R;IGF2R-Specific;Lysosome Marker;M6P R;M6P/IGF2 receptor;M6P/IGF2R;M6PR;MPR 300;MPR1;MPRI 克隆性 Monoclonal 检验物种 human 应用范围 WB,IHC 基因名称 IGF2R 克隆号 6G2 ...
别名:MPR1,MPRI,CD222,CIMPR,M6P-R,MPR300,CI-M6PR,M6P/IGF2R 基因ID:3482 Chromosome: (GRCh37)6Start:160390131End:160527583Strand: 信号通路:细胞增殖细胞周期基因组不稳定凋亡抑制能量代谢 IGF2R 基因突变与药物 请登录后查看 IGF2R基因突变 详细信息。
IGF2R;CD222;CI-M6PR;CIMPR;M6P-R;M6P/IGF2R;MPR 300;MPR1;MPR300;MPRI;insulin like growth factor 2 receptor;cation-independent mannose-6-phosphate receptor;300 kDa mannose 6-phosphate receptor;CI Man-6-P receptor;IGF-II receptor;M6P/IGF2 receptor;insulin-like growth factor II receptor;胰...
IGF2R;CD222;CI-M6PR;CIMPR;M6P-R;M6P/IGF2R;MPR 300;MPR1;MPR300;MPRI;insulin like growth factor 2 receptor;cation-independent mannose-6-phosphate receptor;300 kDa mannose 6-phosphate receptor;CI Man-6-P receptor;IGF-II receptor;M6P/IGF2 receptor;insulin-like growth factor II receptor;胰...
IGF2R, also named as MPRI, CI Man-6-P receptor, CI-MPR, M6PR, IGF-II receptor, M6P/IGF2R, MPR 300 and CD222, belongs to the MRL1/IGF2R family. IGF2R transports of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes. IGF2R is a lysosomal enzym...
Characterization of differential tissue GAA content and CI-M6PR/IGF2R expression using autopsy material obtained from 2 patients with CRIM-negative infantile Pompe disease treated with ERTLC circuitscapacitorsequivalent circuitsfiltering theoryinterference suppressionmicrowave metamaterials...
receptor; CD222 antigen; CD222; CI Man-6-P receptor; CIMPR; CI-MPR; IGF2R; IGF-II R; IGF-II receptor; IGFIIR; IGF-IIR; insulin-like growth factor 2 receptorM6P/IGF2R; Insulin-like growth factor II receptor; M6P/IGF2 receptor; M6PR; M6P-R; MPR 300; MPR1; MPRI; MPRIM6PR...